New Market Study Published: New Zealand In Vitro Diagnostics Market Outlook to 2018

2013-02-01 02:38:59 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

GlobalData's new report, "New Zealand In Vitro Diagnostics Market Outlook to 2018 - " provides key market data on the New Zealand In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within market categories - Clinical Chemistry, Haematology, Immuno Chemistry, Histology And Cytology, Infectious Immunology, Microbiology Culture and Genetic Testing. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Full Report Details at
- www.fastmr.com/prod/532501_new_zealand_in_vitro_diagnostics_mark ..

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house

analysis by GlobalData's team of industry experts.

Scope

* Market size and company share data for In Vitro Diagnostics market categories - Clinical Chemistry, Haematology, Immuno Chemistry, Histology And Cytology, Infectious Immunology, Microbiology Culture and Genetic Testing.
* Annualized market revenues (USD million) data for each of the segments and sub-segments within market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
* 2011 company shares and distribution shares data for each of the market categories.
* Global corporate-level profiles of key companies operating within the New Zealand In Vitro Diagnostics market.
* Key players covered include Sysmex Corporation, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Beckman Coulter, Inc., Siemens Healthcare, Becton, Dickinson and Company and others.

Reasons to buy

* Develop business strategies by identifying the key market categories and segments poised for strong growth.
* Develop market-entry and market expansion strategies.
* Design competition strategies by identifying who-stands-where in the New Zealand In Vitro Diagnostics competitive landscape.
* Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
* What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned in this Report: Sysmex Corporation, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Beckman Coulter, Inc., Siemens Healthcare, Becton, Dickinson and Company, Ortho-Clinical Diagnostics Inc., bioMerieux S.A., Bio-Rad Laboratories, Inc., Alere Inc., Qiagen N.V., Life Technologies Corporation, DiaSorin S.p.A, Horiba, Ltd., Danaher Corporation, Mindray Medical International Limited, Grifols, S.A., PerkinElmer, Inc., Thermo Fisher Scientific Inc., Gen-Probe Incorporated, Diagnostica Stago, Inc., Phadia AB

Partial Table of Contents:

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 In Vitro Diagnostics In New Zealand
3.1 In Vitro Diagnostics, Market Segmentation
3.2 In Vitro Diagnostics, New Zealand, Overall Revenue ($m), USD Constant, 2004-2018
3.3 In Vitro Diagnostics Market, New Zealand, Revenue Mix ($m), 2011
3.4 In Vitro Diagnostics Market, New Zealand, Category Contribution 2011
3.5 In Vitro Diagnostics, New Zealand, Company Share (2010-2011)
4 Clinical Chemistry In New Zealand
4.1 Clinical Chemistry, Market Segmentation
4.2 Clinical Chemistry Market, New Zealand, Revenue Mix ($m), 2011
4.3 Clinical Chemistry Market, New Zealand, Segment Contribution 2011
4.4 Clinical Chemistry Overall Revenue, (2004-2018)
4.4.1 Clinical Chemisty Analyzers, Revenue (2004-2018)
4.4.2 Urine Analysis, Revenue (2004-2018)
4.5 Clinical Chemistry Distribution Share (2010-2011)
4.6 Clinical Chemistry, New Zealand, Company Share (2010-2011)
5 Genetic Testing In New Zealand
5.1 Genetic Testing, Market Segmentation
5.2 Genetic Testing Market, New Zealand, Revenue Mix ($m), 2011
5.3 Genetic Testing Market, New Zealand, Segment Contribution 2011
5.4 Genetic Testing Overall Revenue, (2004-2018)
5.5 Genetic Testing Distribution Share (2010-2011)
5.6 Genetic Testing, New Zealand, Company Share (2010-2011)
6 Haematology In New Zealand
6.1 Haematology Market, Market Segmentation
6.2 Haematology Market, New Zealand, Revenue Mix ($m), 2011
6.3 Haematology Market, New Zealand, Segment Contribution 2011
6.4 Haematology Overall Revenue, (2004-2018)
6.4.1 Haematology Reagents, Revenue (2004-2018)
6.4.2 Immunohaematology, Revenue (2004-2018)
6.4.3 Haemostasis, Revenue (2004-2018)
6.4.4 Haematology Rapid Tests, Revenue (2004-2018)
6.4.5 Haematology Cell Counters, Revenue (2004-2018)
6.5 Haematology Distribution Share (2010-2011)
6.6 Haematology, New Zealand, Company Share (2010-2011)
7 Histology And Cytology In New Zealand
7.1 Histology And Cytology Market, Market Segmentation
7.2 Histology And Cytology Market, New Zealand, Revenue Mix ($m), 2011
7.3 Histology And Cytology Market, New Zealand, Segment Contribution 2011
7.4 Histology And Cytology Overall Revenue, (2004-2018)

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=532501&dt=t

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.